233 related articles for article (PubMed ID: 30099851)
1. Metabolomic profiling of human lung tumor tissues - nucleotide metabolism as a candidate for therapeutic interventions and biomarkers.
Moreno P; Jiménez-Jiménez C; Garrido-Rodríguez M; Calderón-Santiago M; Molina S; Lara-Chica M; Priego-Capote F; Salvatierra Á; Muñoz E; Calzado MA
Mol Oncol; 2018 Oct; 12(10):1778-1796. PubMed ID: 30099851
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
4. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
6. Polyamine Metabolites Profiling for Characterization of Lung and Liver Cancer Using an LC-Tandem MS Method with Multiple Statistical Data Mining Strategies: Discovering Potential Cancer Biomarkers in Human Plasma and Urine.
Xu H; Liu R; He B; Bi CW; Bi K; Li Q
Molecules; 2016 Aug; 21(8):. PubMed ID: 27517900
[TBL] [Abstract][Full Text] [Related]
7. Plasticity in the purine-thiamine metabolic network of Salmonella.
Bazurto JV; Downs DM
Genetics; 2011 Feb; 187(2):623-31. PubMed ID: 21135073
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
9. Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients.
Woo HI; Kim JA; Jung HA; Kim KK; Lee JY; Sun JM; Ahn JS; Park K; Lee SY; Ahn MJ
Pharmacogenomics; 2015; 16(4):383-91. PubMed ID: 25823786
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
11. Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.
Ciborowski M; Kisluk J; Pietrowska K; Samczuk P; Parfieniuk E; Kowalczyk T; Kozlowski M; Kretowski A; Niklinski J
Electrophoresis; 2017 Sep; 38(18):2304-2312. PubMed ID: 28440547
[TBL] [Abstract][Full Text] [Related]
12. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
13. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
14. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic study of serum, urine and bronchoalveolar lavage fluid based on gas chromatography mass spectrometry to delve into the pathology of lung cancer.
Callejón-Leblic B; García-Barrera T; Pereira-Vega A; Gómez-Ariza JL
J Pharm Biomed Anal; 2019 Jan; 163():122-129. PubMed ID: 30292984
[TBL] [Abstract][Full Text] [Related]
16. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
[TBL] [Abstract][Full Text] [Related]
17. Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.
Wen T; Gao L; Wen Z; Wu C; Tan CS; Toh WZ; Ong CN
Mol Biosyst; 2013 Sep; 9(9):2370-8. PubMed ID: 23857124
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
19. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
Lam CW; Law CY
J Proteome Res; 2014 Sep; 13(9):4040-6. PubMed ID: 25117182
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
